Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.74% | 42.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.74% | 42.55% | |||
| Cost of Revenue | -2.75% | -8.76% | |||
| Gross Profit | 2.75% | 34.21% | |||
| SG&A Expenses | -2.75% | -12.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.74% | -10.29% | |||
| Operating Income | 2.75% | 23.12% | |||
| Income Before Tax | 2.75% | 23.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.75% | 23.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.75% | 23.12% | |||
| EBIT | 2.75% | 23.12% | |||
| EBITDA | 2.75% | 23.50% | |||
| EPS Basic | 2.33% | 24.56% | |||
| Normalized Basic EPS | 3.70% | 25.00% | |||
| EPS Diluted | 4.55% | 24.14% | |||
| Normalized Diluted EPS | 3.70% | 25.00% | |||
| Average Basic Shares Outstanding | 0.00% | 1.02% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||